findmyKOL
Clinical trialNCT03765736TerminatedObservational

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

SponsorAcademic and Community Cancer Research UnitedEnrollment199Metastatic Colon AdenocarcinomaMetastatic Rectal AdenocarcinomaStage III Colon Cancer AJCC v8Stage III Rectal Cancer AJCC v8Stage IIIA Colon Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8+14 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic in Arizona

    Scottsdale, Arizona, United States

  • Uc San Diego Moores Cancer Center

    La Jolla, California, United States

  • Cedars Sinai Medical Center

    Los Angeles, California, United States

  • Usc / Norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • Medstar Georgetown University Hospital

    Washington D.C., District of Columbia, United States

  • Mayo Clinic in Florida

    Jacksonville, Florida, United States

  • Emory University Hospital/winship Cancer Institute

    Atlanta, Georgia, United States

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

  • Mayo Clinic in Rochester

    Rochester, Minnesota, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Allegheny General Hospital

    Pittsburgh, Pennsylvania, United States

  • Vanderbilt University/ingram Cancer Center

    Nashville, Tennessee, United States

  • M D Anderson Cancer Center

    Houston, Texas, United States

  • Aurora Cancer Care-Milwaukee

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Apr 2020
Primary completion
1 Dec 2023
Completion
1 Dec 2023
Last update posted
29 Aug 2025
Registered enrollment
199
Registry id
NCT03765736

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.